Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

Item
http://www.wikidata.org/entity/Q42988157
Economic assessment of eltrombopag in the treatment of thrombocytopenia.The current economic burden of cirrhosis.Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany--an application of the efficiency frontier approachEconomic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.Health state utilities associated with attributes of treatments for hepatitis C.Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.Economic Evaluations of Pharmacogenetic Approaches in Infectious Diseases: A Review of Current Approaches and Evaluation of Critical Aspects Affecting their Quality.USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW.Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.
P2860

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

Item
http://www.wikidata.org/entity/Q42988157
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Clinical effectiveness and cos ...... is based on German guidelines.
@en
Clinical effectiveness and cos ...... is based on German guidelines.
@nl
type
label
Clinical effectiveness and cos ...... is based on German guidelines.
@en
Clinical effectiveness and cos ...... is based on German guidelines.
@nl
prefLabel
Clinical effectiveness and cos ...... is based on German guidelines.
@en
Clinical effectiveness and cos ...... is based on German guidelines.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Clinical effectiveness and cos ...... sis based on German guidelines
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/00019053-200927040-00006
P433
P478
P50
P577
P6179
P698